The impact of HIV clinical pharmacists on HIV treatment outcomes: A systematic review

Patient Preference and Adherence

Volumn 6, Issue , 2012, Pages 297-322

  Saberi, Parya ^a   Dong, Betty J ^b   Johnson, Mallory O ^a   Greenblatt, Ruth M ^b   Cocohoba, Jennifer M ^b  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

Adherence; Clinical; HIV AIDS; Impact; Pharmacist

Indexed keywords

ANTIRETROVIRUS AGENT;

CD4 LYMPHOCYTE COUNT; CHEMICAL MODIFICATION; HEALTH CARE UTILIZATION; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; NONHUMAN; PATIENT CARE; PATIENT COMPLIANCE; PHARMACIST ATTITUDE; REVIEW; SYSTEMATIC REVIEW; TREATMENT OUTCOME; VIRUS LOAD;

EID: 84872190143     PISSN: None     EISSN: 1177889X     Source Type: Journal    
DOI: 10.2147/PPA.S30244     Document Type: Review

References (50)

1. Centers for Disease Control (CDC). Pneumocystis pneumonia-Los Angeles. MMWR Morb Mortal Wkly Rep. 1981;30(21):250-252.
2. Corelli RL, Guglielmo BJ, Kapusnik-Uner JE, McMaster JR, Greenblatt RM. Medication usage patterns in patients with human immunodeficiency virus infection: a comparison of patient-reported medication usage with medical chart review. DICP.1991;25(12):1374-1378.
3. Crawford NS. Organizing pharmacists to help fight AIDS. Am Pharm. 1991;NS31(3):44-47.
4. McKnight PT, Visconti JA, Gower RE, Para MF. Zidovudine: counseling strategies and Compliance. Am Pharm. 1991;31(10):38-43.
5. Weingarten CM, Freeland B. Pharmacist participation on an HIV resource team. Am J Health Syst Pharm. 1995;52(12):1282-1284.
6. Foisy MM, Tseng A, Blaikie N. Pharmacists' provision of continuity of care to patients with human immunodeficiency virus infection. Am J Health Syst Pharm. 1996;53(9):1013-1017.
7. Horberg MA, Hurley LB, Towner WJ, et al. WITHDRAWN: Determination of optimized multidisciplinary care team for maximal antiretroviral therapy adherence. J Acquir Immune Defic Syndr. January 30, 2012. [Epub ahead of print]
8. Lefebvre C, Manheimer E, Glanville J. Searching for studies. In: Higgins JPT, Green S, editors. Cochrane Handbook for Systematic Reviews of Interventions Version 5.1.0 (Updated March 2011). The Cochrane Collaboration; 2011.
9. Reeves BC, Deeks JJ, Higgins JPT, Wells GA. Including non-randomized studies. In: Higgins JPT, Green S, editors. Cochrane Handbook for Systematic Reviews of Interventions (Version 5.0.1): The Cochrane Collaboration; 2008.
10. Ostrop NJ, Gill MJ. Antiretroviral medication adherence and persistence with respect to adherence tool usage. AIDS Patient Care STDs. 2000;14(7):351-358.
11. McPherson-Baker S, Malow RM, Penedo F, Jones DL, Schneiderman N, Klimas NG. Enhancing adherence to combination antiretroviral therapy in non-adherent HIV-positive men. AIDS Care. 2000;12(4):399-404.
12. Mathews WC, Mar-Tang M, Ballard C, et al. Prevalence, predictors, and outcomes of early adherence after starting or changing antiretroviral therapy. AIDS Patient Care STDs. 2002;16(4):157-172.
13. Smith SR, Rublein JC, Marcus C, Brock TP, Chesney MA. A medication self-management program to improve adherence to HIV therapy regimens. Patient Educ Couns. 2003;50(2):187-199.
14. Castillo E, Palepu A, Beardsell A, et al. Outpatient pharmacy care and HIV viral load response among patients on HAART. AIDS Care. 2004;16(4):446-457.
15. Levy RW, Rayner CR, Fairley CK, et al for Melbourne Adherence Group. Multidisciplinary HIV adherence intervention: a randomized study. AIDS Patient Care STDs. 2004;18(12):728-735.
16. Gross R, Zhang Y, Grossberg R. Medication refill logistics and refill adherence in HIV. Pharmaco epidemiol Drug Saf. 2005;14(11): 789-793.
17. Rathbun RC, Farmer KC, Stephens JR, Lockhart SM. Impact of an adherence clinic on behavioral outcomes and virologic response in treatment of HIV infection: a prospective, randomized, controlled pilot study. Clin Ther. 2005;27(2):199-209.
18. Frick P, Tapia K, Grant P, Novotny M, Kerzee J. The effect of a multidisciplinary program on HAART adherence. AIDS Patient Care STDs. 2006;20(7):511-524.
19. Visnegarwala F, Rodriguez-Barradass MC, Graviss EA, Caprio M, Nykyforchyn M, Laufman L. Community outreach with weekly delivery of anti-retroviral drugs compared to cognitive-behavioural health care team-based approach to improve adherence among indigent women newly starting HAART. AIDS Care. 2006;18(4):332-338.
20. March K, Mak M, Louie SG. Effects of pharmacists' interventions on patient outcomes in an HIV primary care clinic. Am J Health Syst Pharm. 2007;64(24):2574-2578.
21. Horberg MA, Hurley LB, Silverberg MJ, Kinsman CJ, Quesenberry CP. Effect of clinical pharmacists on utilization of and clinical response to antiretroviral therapy. J Acquir Immune Defic Syndr. 2007;44(5): 531-539.
22. Hirsch JD, Rosenquist A, Best BM, Miller TA, Gilmer TP. Evaluation of the first year of a pilot program in community pharmacy: HIV/AIDS medication therapy management for Medi-Cal beneficiaries. J Manag Care Pharm. 2009;15(1):32-41.
23. Pirkle CM, Boileau C, Nguyen VK, et al. Impact of a modified directly administered antiretroviral treatment intervention on virological outcome in HIV-infected patients treated in Burkina Faso and Mali. HIV Med. 2009;10(3):152-156.
24. Krummenacher I, Cavassini M, Bugnon O, Spirig R, Schneider MP, for Swiss HIV Cohort Study. Antiretroviral adherence program in HIV patients: a feasibility study in the Swiss HIV Cohort Study. Pharm World Sci. 2010;32(6):776-786. Epub September 23, 2010.
25. Ma A, Chen DM, Chau FM, Saberi P. Improving adherence and clinical outcomes through an HIV pharmacist's interventions. AIDS Care. 2010;22(10):1189-1194.
26. Hirsch JD, Gonzales M, Rosenquist A, Miller TA, Gilmer TP, Best BM. Antiretroviral therapy adherence, medication use, and health care costs during 3 years of a community pharmacy medication therapy management program for Medi-Cal beneficiaries with HIV/AIDS. Journal Manag Care Pharm. 2011;17(3):213-223.
27. Krummenacher I, Cavassini M, Bugnon O, Schneider MP. An interdisciplinary HIV-adherence program combining motivational interviewing and electronic antiretroviral drug monitoring. AIDS Care. 2011;23(5):550-561.
28. Henderson KC, Hindman J, Johnson SC, Valuck RJ, Kiser JJ. Assessing the effectiveness of pharmacy-based adherence interventions on antiretroviral adherence in persons with HIV. AIDS Patient Care STDs. 2011;25(4):221-228. Epub Feburary 16, 2011.
29. Walji N, Beardsell A, Brown G. Pharmacists' activities in monitoring zidovudine therapy in an AIDS clinic. Can J Hosp Pharm. 1992;45(1): 29-32.
30. Geletko SM, Segarra M, Copeland DA, Teague AC. Pharmaceutical care for hospitalized HIV-infected patients compared to infectious diseases consult patients without HIV infection. BMJ Pharmacotherapy. 1996;2(1):45-57.
31. Bozek PS, Perdue BE, Bar-Din M, Weidle PJ. Effect of pharmacist interventions on medication use and cost in hospitalized patients with or without HIV infection. Am J Health Syst Pharm. 1998;55(11): 1151-1155.
32. Garey KW, Teichner P. Pharmacist intervention program for hospitalized patients with HIV infection. Am J Health Syst Pharm. 2000;57(24):2283-2284.
33. Geletko SM, Poulakos MN. Pharmaceutical services in an HIV clinic. Am J Health Syst Pharm. 2002;59(8):709-713.
34. Segarra-Newnham M. Preventing medication errors with a pharmacy admission note for HIV-positive patients. Hosp Pharm. 2002;37(1): 34-37.
35. De Maat MMR, De Boer A, Koks CHW, et al. Evaluation of clinical pharmacist interventions on drug interactions in outpatient pharmaceutical HIV-care. J Clin Pharm Ther. 2004;29(2):121-130.
36. Foisy MM, Akai PS. Pharmaceutical care for HIV patients on directly observed therapy. Ann Pharmacother. 2004;38(4):550-556. Epub Feburary 27, 2004.
37. Sterling ES, Romanelli F, Martin CA, Hoven AD, Smith KM. Impact of a pharmacy-initiated HIV admission note on medication errors within an academic hospital. Hosp Pharm. 2005;40(10):874-881.
38. Heelon M, Skiest D, Tereso G, et al. Effect of a clinical pharmacist's interventions on duration of antiretroviral-related errors in hospitalized patients. Am J Health Syst Pharm. 2007;64(19):2064-2068.
39. Pastakia SD, Corbett AH, Raasch RH, Napravnik S, Correll TA. Frequency of HIV-related medication errors and associated risk factors in hospitalized patients. Ann Pharmacother. 2008;42(4):491-497.
40. Horace A, Philips M. Identification and prevention of antiretroviral medication errors at an academic medical center. Hosp Pharm. 2010;45(12):927-933.
41. Carcelero E, Tuset M, Martin M, et al. Evaluation of antiretroviralrelated errors and interventions by the clinical pharmacist in hospitalized HIV-infected patients. HIV Med. 2011;12(8):494-499. doi: 10.1111/j.1468-1293.2011.00915.x. Epub March 13, 2011.
42. Case PL. Feasibility of pharmacy-based HIV intervention among IDUs: 2 New England cities. National Institutes of Health Project Reporter (project number: R21DA025010); 2010. Available from: BioMedLib. com.
43. Fuller CM. Pharmacy referral intervention: IDU access to services. National Institutes of Health Project Reporter (project number: R01DA022144); 2010. Available from: BioMedLib. com.
44. Latkin CA. Feasibility of pharmacy-based HIV interventions among IDUs: India. National Institutes of Health Project Reporter (project number: R21DA024971); 2010. Available from: BioMedLib. com.
45. Pielemeier N. Feasibility of pharmacy-based HIV interventions among IDUs: Ha Giang, Vietnam. National Institutes of Health Project Reporter (project number: R21DA024986); 2010. Available from: BioMedLib. com.
46. Fisher JD, Fisher WA, Misovich SJ, Kimble DL, Malloy TE. Changing AIDS risk behavior: effects of an intervention emphasizing AIDS risk reduction information, motivation, and behavioral skills in a college student population. Health Psychol. 1996;15(2):114-123.
47. Amico KR, Toro-Alfonso J, Fisher JD. An empirical test of the information, motivation and behavioral skills model of antiretroviral therapy adherence. AIDS Care. 2005;17(6):661-673.
48. Cocohoba JM. Beyond pill-counting: effect of pharmacist counseling on antiretroviral adherence. National Institutes of Health Project Reporter (project number: K23MH087218); 2011. Available from: BioMedLib. com.
49. Hospital de Clinicas de Porto Alegre; Federal University of Rio Grande do Sul. Evaluation of effectiveness of pharmaceutical care on the adherence of HIV-positive patients to antiretroviral therapy (PC-HIV). In: ClinicalTrials. gov [website on the internet]. Bethesda, MD: US National Library of Medicine, 2009. Available from: clinicaltrials. gov/ct2/show/NCT00959361. NLM identifier: NCT00959361.
50. Wilson IB. Nudging doctors to collaborate with pharmacists to improve medication adherence. National Institutes of Health Project Reporter (project number: RC4AG039072); 2010. Available from: BioMedLib. com.